Isovorin + UFT
Phase 3Completed 1 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Colon Cancer
Conditions
Colon Cancer
Trial Timeline
Oct 1, 2002 → Feb 1, 2006
NCT ID
NCT00195585About Isovorin + UFT
Isovorin + UFT is a phase 3 stage product being developed by Pfizer for Colon Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT00195585. Target conditions include Colon Cancer.
What happened to similar drugs?
4 of 13 similar drugs in Colon Cancer were approved
Approved (4) Terminated (5) Active (5)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00195585 | Phase 3 | Completed |
Competing Products
20 competing products in Colon Cancer